We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 414

European General Court upholds findings of abuse of dominant position by AstraZeneca for misusing the SPC and marketing authorising systems

  • Bird & Bird
  • -
  • European Union
  • -
  • July 28 2010

The European General Court issued its judgment on 1 July 2010 on AstraZeneca's appeal against the European Commission's decision adopted on 15 June 2005 fining AstraZeneca ("AZ") EUR 60 million for abuse of dominant position through misuse of the patent system to obtain supplementary protection certificates (SPCs) and misuse of the pharmaceutical regulatory system by selective withdrawal of certain marketing authorisations

Virgin Atlantic Airways Ltd v Premium Aircraft Interiors UK Ltd: subsequent patent claim amendment and res judicata

  • McDermott Will & Emery
  • -
  • European Union, United Kingdom
  • -
  • March 31 2011

Following an infringement action between the parties, the Court of Appeal had held the Claimant's patent valid and infringed and made an order for damages, an injunction and a series of undertakings

High court reaffirms no copyright protection for computer program functionality

  • RPC
  • -
  • European Union, United Kingdom
  • -
  • March 4 2013

In what should be the final instalment in a long-running case, a decision was recently issued in SAS Institute Inc v World Programming Ltd following

Medeva's SPC applications: the Court of Appeal refers questions to the ECJ

  • Wragge Lawrence Graham & Co LLP
  • -
  • European Union, United Kingdom
  • -
  • July 7 2010

The Court of Appeal has decided to refer a series of questions on the interpretation of the SPC Regulation to the Court of Justice of the European Union (CJEU) relating to the requirement that a "product is protected by a basic patent"

Software and business methods patentable subject-matter in Europe?

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • European Union, United Kingdom, USA
  • -
  • October 21 2013

The CLS Bank case (CLS Bank Int'l v. Alice Corp. Pty. Ltd., 2011-1301) decision issued by the Court of Appeals for the Federal Circuit highlighted

Preview 2013 (UK law)

  • Herbert Smith Freehills LLP
  • -
  • European Union, United Kingdom
  • -
  • January 15 2013

2013 will herald some significant changes to the UK legal arena, notably in the corporate area in relation to executive remuneration and narrative

ECJ declares proposed European and Community patents court unconstitutional

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • March 15 2011

On 8 March 2011, the European Court of Justice handed down its Opinion No 109, in which it found that the proposed agreement on the community patents court is not compatible with the provisions of the European Union Treaties

Minus 3 months and 2 weeks

  • Norrbom Vinding
  • -
  • European Union, Germany
  • -
  • September 15 2011

The EU Advocate General says that supplementary protection certificates can be issued with a negative term

Advocate General recommends dismissal of AstraZeneca appeal

  • Mayer Brown LLP
  • -
  • European Union
  • -
  • May 22 2012

On 15 May 2012, Advocate General Mazak gave an opinion on AstraZeneca’s appeal against a General Court judgment which largely upheld the European Commission’s decision to fine AstraZeneca for abusive patent misuse

SPC reference to the CJEU and combination drug cross-undertaking granted

  • McDermott Will & Emery
  • -
  • European Union, United Kingdom
  • -
  • November 7 2013

In Actavis Group PTC EHF & Anor v Boehringer Ingelheim Pharma GmbH & Co, KG 2013 EWHC 2927 (Pat), the High Court of England and Wales agreed to